KIF26B and hepatocellular carcinoma: Results indicated that lymph node status (HR: 2.548, 95% CI: 1.267–5.126, P = 0.009), clinical stage (HR: 2.273, 95% CI: 1.278–4.044, P = 0.005), and KIF26B (HR: 2.356, 95% CI: 1.268–4.378, P = 0.007) were also independent predictor for DFS of HCC patients (Table 3).